Are you sure you want to log out?
Cannabidiol in inflammatory bowel diseases: A brief overview
CBDreduces intestinal inflammation through the control of neuroimmune axis
Clinical endocannabinoid deficiency (CECD): Can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
Cannabinoid actions atTRPV channels: Effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
Therapeutic potential of cannabinoid-based drugs
Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Biochemical Pharmacology)
CBDand the gut: New developments and emerging concepts
Endocannabinoids and the gastrointestinal tract
CBDand gastrointestinal motility
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
Cannabinoids andGI Disorders: Endogenous and Exogenous
1111 Brickell Avenue
Miami, FL 33131